ÌÇÐÄÔ­´´

The ÌÇÐÄÔ­´´ is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.

A new MRI study could reveal why some people are more likely to become obese than others by examining what happens in the brain and gut when people consume food high in fat and carbohydrate.

Experts from the ÌÇÐÄÔ­´´ are looking for volunteers to take part in an MRI study into a common treatment for constipation.

A wearable brain scanner is being used, for the first time, to investigate the brain activity in elderly people whilst driving a car.

An ambitious plant-based food company supported by the Food Innovation Centre in its infancy has raised £1.6 million via crowdfunding.

One of the world’s most powerful supercomputers is being used by chemists at the ÌÇÐÄÔ­´´ to accelerate research into the discovery of new medicines.

Scientists are using the latest Digital technology to support the development of machine learning models of sustainable chemistry that can be used in the early phase of drug discovery.

The ÌÇÐÄÔ­´´ has joined the newly launched UK-Singapore Alliance for Entrepreneurship and Innovation (UKSAEI) – the first alliance of its kind to accelerate collaborations in entrepreneurship and innovation between the two countries.

Researchers have been awarded funding to work with a global leader in the speciality chemicals industry to create cleaner and greener chemical processing methods for everyday products in a bid to help the government meet its carbon neutral targets.

Actiphage®, is a rapid, accurate test for bovine tuberculosis (bTB) that would enable farmers to effectively remove this devastating disease from their herds. PBD Biotech has secured a £2.3m investment to take Actiphage through to validation by the World Organisation for Animal Health (OIE). Full validation will enable international adoption of this novel, patented, diagnostic for mycobacterial diseases, which include human tuberculosis and Johne’s Disease.